Share-based Payment Arrangement, Expense of Sensei Biotherapeutics, Inc. from 31 Mar 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Sensei Biotherapeutics, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2020 to 30 Sep 2025.
  • Sensei Biotherapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $254,000, a 65% decline year-over-year.
  • Sensei Biotherapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $1,370,000, a 64% decline year-over-year.
  • Sensei Biotherapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $3,135,000, a 30% decline from 2023.
  • Sensei Biotherapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $4,454,000, a 23% decline from 2022.
  • Sensei Biotherapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5,812,000, a 2.7% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Sensei Biotherapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,370,000 $254,000 -$479,000 -65% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $1,849,000 $264,000 -$531,000 -67% 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $2,380,000 $461,000 -$755,000 -62% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $3,135,000 $391,000 -$707,000 -64% 01 Oct 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
Q3 2024 $3,842,000 $733,000 -$315,000 -30% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 $4,157,000 $795,000 -$300,000 -27% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025 2025 Q2
Q1 2024 $4,457,000 $1,216,000 +$3,000 +0.25% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q4 2023 $4,454,000 $1,098,000 -$324,000 -23% 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 $4,778,000 $1,048,000 -$431,000 -29% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $5,209,000 $1,095,000 -$301,000 -22% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 $5,510,000 $1,213,000 -$302,000 -20% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $5,812,000 $1,422,000 +$595,000 +72% 01 Oct 2022 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $5,217,000 $1,479,000 -$257,000 -15% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 $5,474,000 $1,396,000 -$349,000 -20% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 $5,823,000 $1,515,000 +$166,000 +12% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $5,657,000 $827,000 +$473,000 +134% 01 Oct 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $5,184,000 $1,736,000 +$955,000 +122% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $4,229,000 $1,745,000 +$1,582,000 +971% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $2,647,000 $1,349,000 +$1,155,000 +595% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $1,492,000 $354,000 01 Oct 2020 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 $781,000 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $163,000 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021 2021 Q2
Q1 2020 $194,000 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1

Sensei Biotherapeutics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $3,135,000 -$1,319,000 -30% 01 Jan 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
2023 $4,454,000 -$1,358,000 -23% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
2022 $5,812,000 +$155,000 +2.7% 01 Jan 2022 31 Dec 2022 10-K 29 Feb 2024 2023 FY
2021 $5,657,000 +$4,165,000 +279% 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
2020 $1,492,000 01 Jan 2020 31 Dec 2020 10-K 15 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.